Share this video  

ASCO 2022 | Optimizing timing of vaccinations and chemotherapy

Eva Segelov, MBBS, PhD, FRACP, Monash University, Melbourne, Australia, discusses data collected from the prospective, observational study, SerOzNET (ACTRN12621001004853) study on whether patients were on treatment with steroids at the time of receiving the COVD-19 vaccine to aid in optimizing the timing of vaccinations and chemotherapy. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.